Clinical Trial Update: A Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) With Pembrolizumab in Participants With Selected Hyaluronan High Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating PEGPH20 with pembrolizumab in hyaluronan-high tumors including non-small cell lung cancer and gastric cancer; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• PEGPH20 (pegylated hyaluronidase)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Halozyme Therapeutics | Conditions: NSCLC, Gastric Cancer | Phase 1 | Status: COMPLETED | Results posted: 2020-02-07